November 8, 2022 · STOCK Act disclosure
Representative Chris Jacobs (Republican-NY) bought Relmada Therapeutics, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on November 8, 2022 and was disclosed on December 12, 2022 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.